FDA Approves EVENITY(TM) (romosozumab-aqqg) For The TreatmentAMGN: Amgen
2019-04-09 15:57:00
FDA Approves EVENITY(TM) (romosozumab-aqqg) For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk For Fracture - PR Newswire
AMGN trade ideas
Double top for AMGNI believe this is a confirmed double top for AMGN, which is the end for its nice run up that began with a double bottom..
I will look into this stock after a $18-25 pull back...
AMGN Downtrend Current Downtrend, this could range for awhile. I do enjoy trading this ticker, ill consider taking short positions near top of downtrend line but I don't plan on taking long positions until the trend changes.
AMGEN Misses$AMGN At trendline support. A break would be bearish, possibly setting up a move back to the origin of the entire advance.
AMGN - trade setupLike this gap down.. I'll wait for the first 5 min candle and play the break of that. Since this is a red candle gaping down it could retest then roll over.c Might take a few min to really break down or just head fake and go back up.
FDA Approves Nplate® (Romiplostim) For Use In Pediatric PatientsAMGN: Amgen
2018-12-14 16:00:00
FDA Approves Nplate® (Romiplostim) For Use In Pediatric Patients With Immune Thrombocytopenia
AMGN - Amgen Stock SpeculationHere we have Amgen Stock chart. Bigger picture suggesting that there is more room to fall until we reach significant areas of demand. As we move to the lower time frame we can see fresh supply sitting above and very little demand below. Will look for an entry here.
[AMGEN] Phase 2 but starting phase 3?If in monday the price break the support so it's starting phase 3.
Observing AMGEN Inc (Biotech company)I've drawn some levels based on VolumeProfileMarket of current "expiration session". Let's see how it will behave. Probably I will try even to enter to it
AMGN is expected to increase further... The target price of the current exchange rate is around 231 usd. We expect an ABC waveform correction from the level. The endpoint of this correction is a D1 ATR axis around 190 usd. There is a further rise in the level of this level.
Tezepelumab Granted Breakthrough Therapy Designation By US FDAAMGN : Amgen
2018-09-07 02:00:00
Tezepelumab Granted Breakthrough Therapy Designation By US FDA For The Treatment Of Patients With Severe Asthma Without An Eosinophilic Phenotype
Live example of a market cycle euphoria phase coming to an endWhat happens when a car keeps going forward, but slows down?
Same principle.
Here is a quick summary about market cycles:
www.investopedia.com
If 200$ was indeed the top, what we should see next are lower highs. And a long bear market.
It has already been going up with less strength for a while. Retail investors getting dumped on.
Well I say retail investors, but institutions too, they don't do anything special.
The difference is institutions will be the first to "panic" sell when shit hits the fan.
It will be too hard for retail to do, but trust me, when something is hard to do, most of the time it is a very good idea to do it.
Making the hard choices is what the masses cannot do, and being able to do that gives you an incredible edge.
That... or being logical to start with and not emotional lol... I personally fail to see the logic. That should not even be a hard decision, just binary.
Oh and by the way, having your money managed by pro's does not shield you if you invest in overvalued crap (not saying AMGEN is crap).
Novogratz crypto fund dropped by 30%, his clients money is gone.
"Strength in numbers" does not apply to finance :p
Think of it rather like cattle going to the slaughterhouse. Do they have strength in numbers?
Get ready to see Amgen feature on bagholderquotes, in a few months, by 2020 at the very most:
twitter.com
AMGN LONGAMGN pretty good breakout point.
Nice riskreward for long entry.
holding Period : 3 to 6 Months
amgn short at 195.80Iam waiting to get a pullback to get short on this baby!
195.80 is a good price to go short all the way to 180
